News Center
Contact us
中文
About Us
Who we are
Our history
Brand culture
Our Businesses
Pharma
Medical
Diagnostics
Vaccines
Sustainability
EHS Responsibility
Education Projects
Charitable Donations
Community Services
Join us
People Strategy
Our People
Job Opportunities
News Center
Boan Biotech Announces 2024 Half Year Results: Revenue Grows by 39%, Net Profit Increases ...
2024-08-28
MORE>
Luye Pharma Announces U.S. FDA Approval of ERZOFRI® for Treating Schizophrenia and Schizoa...
2024-07-30
MORE>
Luye Pharma’s Analgesic Drug Mimeixin (Oxycodone Hydrochloride and Naloxone Hydrochloride...
2024-07-04
MORE>
Luye Pharma’s Jinyouping (Rotigotine Microspheres for Injection) Approved for Marketing ...
2024-06-21
MORE>
Luye Pharma's Meibirui (Paliperidone Palmitate Injection) Approved for Marketing in China...
2024-06-12
MORE>
NDA for Luye Pharma’s Rivastigmine Twice Weekly Transdermal Patch Filed in Japan for Trea...
2024-06-07
MORE>
Total:
143
/ Page:
24
First
Prev
2
3
4
5
6
Next
Last
鲁ICP备05023892号-5
LUYE All Rights Reserved
Privacy policy
Terms of use
中文
TOP
TOP